The global hematology analyzer market size was valued at $7.3 billion in 2022, and is projected to reach $11.5 billion by 2030, registering a CAGR of 6.6% during the forecast period (2023-2030). The major factors for the growth of the hematology analyzers market include the rising burden of blood disorders, increasing technological advancements, and rising adoption rates of automated hematology instruments. Blood disorders have become a global health issue with different causes and are associated with high mortality. Blood disorders, such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood, affect millions of people each year across all age groups.
Browse the full report description of “Hematology Analyzer Market Size, Share & Trends Analysis Report by Product & Service (Instruments, Reagent & Consumables, and Services), by Type (Fully-Automated and Semi-Automated), and by End User (Hospitals, Clinical Laboratories, Research Institutes, and Others) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/hematology-analyzer-market
Furthermore, with advancements in technology and the availability of these instruments across the world coupled with affordability the market is projected to have notable growth. Similarly, convenience and accurate results are the two major reasons driving the growth of the segment over the forecast period. The initiatives by market players such as product launches is another factor contributing to the market growth over the forecast period. For instance, in April 2022, Sysmex Europe launched its new three-part differential automated hematology analyzer, XQ-320. It is a robust device with low demands for sample volume, bench space, and maintenance in Europe. Moreover, for instance, in July 2022, CellaVision launched DIFF-Line. CellaVision DC-1 is a single-slide analyzer that automates and digitizes the process of analyzing peripheral blood smears. Thus, such product launches are expected to increase market growth over the forecast period. However, the high cost of hematology analyzers and time-consuming and stringent regulatory policies associated with the same is restraining the overall market growth.
Furthermore, many centers in the state are international leaders in the diagnosis and treatment of blood diseases and collaborate in many research projects to improve diagnosis and treatment options for blood diseases. Many market players are present in the country and are continuously focusing on the development and introduction of novel products.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Product & Service
o By Type
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Abbott Laboratories, HORIBA Ltd, Siemens Healthineers, Sysmex Corporation, Danaher Corporation, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Hematology Analyzer Market Report Segment
By Product & Service
By Type
By End User
Global Hematology Analyzer Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/hematology-analyzer-market